Go Back

Company or ticker...

Novavax

Novavax develops protein-based vaccines and vaccine technology designed to prevent infectious diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

NVAX

1.6B

4.3

n/a

47.19%

Key Facts

M. Cap

PS

PE

YTD

1.6B

4.3

n/a

47.19%

10MA

20MA

50MA

200MA

$NVAX

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now